Objective: Colorectal neoplasia differentially expressed (CRNDE), a vital cancerrelated long non-coding RNA (lncRNA), has been brought to reports for playing quintessential functions in the growth and progression of several human malignancies.
| INTRODUCTION
Pancreatic cancer emerges as the fourth leading reason of cancerassociated expiries across the globe, exhibiting a general 5-year survival rate of approximately 5 per cent together with a median survival of less than 6 months. 1 For the moment, surgical resection and systemic chemo-radiotherapy are termed as the key options for pancreatic cancer treatment. 2 Because of early aggressive malignant behaviour together with the lack of early diagnostic markers, the survival rate of pancreatic cancer stays exceptionally poor, even though there have been made developments in treatment strategies. 3 There is still a very poor understanding of the molecular mechanisms underlying pancreatic cancer tumorigenesis and progression. Therefore, it poses an emergency situation for us to develop a better understand of the molecular mechanisms underlying pancreatic cancer progression in order to discover effective diagnosis and novel therapeutic targets.
There are reports that long non-coding RNAs (lncRNAs), that are a type of non-coding genes with more than 200 nucleotides in length, perform quintessential regulatory function in a series of biological mechanism, for instance cell proliferation, apoptosis, differentiation and cancer metastasis. 4, 5 Accumulating evidence has revealed that aberrant expressions of lncRNAs exhibit close association with several kinds of human cancers, including pancreatic cancer. [6] [7] [8] [9] LncRNAs are capable of performing as oncogenes or tumour suppressors through the regulation of the expression of tumour-associated genes, in addition to playing the role of tumour-associated pathways, depending on the circumstance. 10, 11 Colorectal neoplasia differentially expressed (colorectal neoplasia differentially expressed), an lncRNA that is located on the long arm of chromosome 16 of the human genome, was originally found to be elevated in colorectal cancer. 12 It has been demonstrated by the past research works that CRNDE dysregulation promotes tumorigenesis in different types of human cancers, including breast cancer, 13 colorectal cancer, 14 hepatic carcinoma 15 and gallbladder carcinoma. 16 Furthermore, upregulation of CRNDE expression exhibits a close association with substandard prognosis as well as aggressive clinical features. Although CRNDE plays critical roles in different cancers, there is a little amount of information available regarding its expression and functional processes in pancreatic cancer.
In a currently stated regulatory process, lncRNAs are likely to function as competing endogenous RNAs (ceRNAs), performing as molecular sponges of microRNAs (miRNAs) for the regulation of miRNA expression, thereby modulates the specific genes targeted by miRNA. 17 For example, lncRNA CRNDE plays its role being a ceRNA for the promotion of metastasis through sponging miR-136 in colorec- and miRNA in pancreatic cancer as yet.
In the current research work, it has been discovered by us that CRNDE is upregulated in pancreatic cancer tissues, together with having close association with the progression of pancreatic cancer and poor overall survival. Moreover, we demonstrated that CRNDE is able to directly interact with miR-384 for the promotion of pancreatic cancer cell proliferation, migration and invasion. Therefore, CRNDE is likely to offer its services as a predictor as well as a potential therapeutic target in respect to pancreatic cancer. 
| MATERIALS AND METHODS

| Clinical specimens
| RNA extraction and qRT-PCR assay
With the use TRIzol Reagent (Invitrogen), the extraction of total RNA was from tissues as well as cell lines was carried out in accordance and 5′-TTGCTGAGGTCATTTAGGTCTT-3′ (reverse).
| Cell Counting Kit-8 (CCK-8) assay
Cell Counting Kit-8 (CCK-8, Beyotime, Shanghai, China) assay was performed in accordance with the guidelines of the manufacturer for detecting cell proliferation. Subsequent to the plating of cells in 96-well plates, at varied stages, the addition of CCK-8 reagents was made to every well. Determination of cellular feasibility was made through the measurement of the absorbance at the wavelength of 450 nm with the use of a microplate reader.
| Colony formation assay
Cells were plated in six-well plates at approximately 1.0 × 10 
| Cell migration and invasion assays
Both the migratory and invasive potential of pancreatic cancer cells were evaluated using transwell assays. For the migration assay, suspension of transfected cells was made in serum-free medium and plated into the transwell chambers (Corning Costar, NY, USA). As regards the invasion assay, addition of the cells in serum-free medium was made into the transwell chambers that contained a Matrigelcoated membrane (BD Bioscience, San Jose, CA, USA). In a brief, medium having 10 per cent FBS was incorporated into the matched lower chambers as the chemoattractant. Subsequent to incubation for a period of 24 hours, using a cotton swab, removal of pancreatic cancer cells on the upper surface of the filter was made. Thereafter, the migrated or invaded cells on the lower surface were preset with 4 per cent formaldehyde, followed by staining with 0.1% crystal violet, and counting in five randomly assigned fields under a microscope of each filter.
| Luciferase reporter assays
The luciferase reporter assays were carried out with the help of the Dual-luciferase Reporter Assay System (Promega, Madison, WI, USA).
The wide-type CRNDE or mutant CRNDE that had the predicted miR-384 binding site was established and integrated into a pmir- HEK293T cells. 48 hours following the transfection, the relative luciferase activities were detected.
| Western blot analysis
Aggregate proteins in the cells were lysed using RIPA buffer (RadioImmunoprecipitation assay buffer, Beyotime). Furthermore, the concentrations were detected with the help of a BCA Protein Assay Kit (Beyotime). Segregation of equivalent quantities of proteins was made using the 10 per cent SDS-PAGE, followed by transferring to PVDF membranes (Millipore, Boston, MA, USA). Thereafter, the incubation of membranes was performed with primary antibodies against IRS1
and GAPDH (Abcam, MA, USA) at 4°C of temperature for the night.
After washes, incubation of the membranes was performed with HRPconjugated secondary antibodies at the room temperature for a time period of 2 hours. GAPDH was put to use as an internal loading control. The analysis of the findings was performed with the help of the ECL detection system (Pierce Biotechnology, Rockford, IL, USA).
| Animal experiments
The purchase of 4 week old female BALB/c nude mice was made from 
| Immunohistochemistry (IHC) analysis
Tumour tissues from nude mice were fixed in 10% formalin and embedded with paraffin. Endogenous peroxidase activity was inhibited by 0.3% hydrogen peroxide for 30 minutes at room temperature.
The sections were next incubated with primary antibody against Ki-67 (Abcam) overnight at 4°C. Following washing with PBS, (phosphate buffered saline, Sigma) the sections were incubated with secondary antibody for 2 hours at room temperature. The products were then assessed using a microscope (×400).
| Statistical analysis
The presentation of the data has been made as the mean ± SD from at least three sovereign experiments. Statistical analyses were carried out with the use of SPSS 18.0 software (SPSS, Chicago, IL, USA), together with generating the graphs using GraphPad Prism 6.0 (GraphPad Prism, San Diego, CA, USA). The relationship between CRNDE expression and clinical characteristics of patients with pancreatic cancer was evaluated with the application of the chi-squared test. With the use of Kaplan-Meier survival analysis, the assessment of overall survival curve was performed, whereas the comparison was performed using the log-rank test. Analyses were carried out for the dissimilarities between groups through the application of Student's t test, one-way ANOVA analysis and Pearson's correlation analysis.
P < .05 was taken into consideration to be statistically significant. F I G U R E 2 Colorectal neoplasia differentially expressed (CRNDE) knockdown inhibits pancreatic cancer cell proliferation, migration and invasion in vitro. A, CRNDE knockdown was achieved by CRNDE siRNA, and the inhibitory efficiency was verified by quantitative real-time PCR (qRT-PCR) analysis. B and C, CCK-8 assay was performed to measure the proliferation of PANC-1 and SW1990 cells after transfected with si-CRNDE compared to si-NC group. D, Colony formation assay was performed to measure the proliferation of PANC-1 and SW1990 cells after transfection. E and F, transwell assays were performed to determine the effects of CRNDE knockdown on pancreatic cancer cell migration and invasion. **P < .01, ***P < .001
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| RESULTS
| CRNDE expression is upregulated in pancreatic cancer tissues and cell lines
For the purpose of determining whether CRNDE was dysregulated in Table 1 ). The prognostic value of CRNDE expression was determined for overall survival in respect of 58 patients with pancreatic
cancer by the Kaplan-Meier survival analysis. It was also discovered by us that high expression of CRNDE had considerable correlation with shorter overall survival in patients with pancreatic cancer ( Figure 1C ). To further explore the functions of CRNDE in pancreatic cancer metastasis, the impacts of CRNDE on pancreatic cancer cell migration and invasion were examined with the use of the transwell assays.
| CRNDE knockdown inhibits pancreatic cancer cell proliferation, migration and invasion in vitro
As shown in Figure 2E 
| CRNDE directly interacts with miR-384
It has been revealed by the past researches that several lncRNAs are likely to act as ceRNAs for particular miRNAs. Through bioinformatics database (starBase v2.0), we identified miR-384 as a potential binding target of CRNDE ( Figure 3A ). To find out the direct binding between CRNDE and miR-384, the dual-luciferase reporter assays were carried out. CRNDE-wt or CRNDE-mut was cotransfected with miR-384 mimics or negative control into HEK293T cells, respectively. The results revealed that miR-384 overexpression considerably reduced the luciferase activity of the CRNDE-wt luciferase reporter vector compared with negative control, while miR-384 overexpression did not pose any impact on the luciferase activity of CRNDE-mut ( Figure 3B ).
To carry out further investigation of the interaction between
CRNDE and miR-384, the relative expression levels of miR-384 in PANC-1 as well as SW1990 cells transfected with CRNDE siRNA were detected. As evident from the Figure 3C , knockdown of CRNDE expression markedly increased miR-384 expression in both cells.
However, there was no obvious change in the CRNDE expression after transfection with miR-384 mimics in PANC-1 and SW1990 cells ( Figure 3D ). and BxPC-3) were markedly decreased compared with that in normal pancreatic cells (HPDE6-C7) ( Figure 3F ). Pearson's correlation analysis revealed CRNDE and miR-384 expressions were inversely correlated in pancreatic cancer tissues ( Figure 3G ). These data made strong suggestions that CRNDE directly targeted as well as negatively regulated miR-384 in pancreatic cancer.
| CRNDE regulates pancreatic cancer cell growth and metastasis through miR-384
Our previous results demonstrated that CRNDE knockdown resulted into the inhibition of cell proliferation, migration and invasion in pancreatic cancer. We further performed investigation whether miR-384 F I G U R E 3 Colorectal neoplasia differentially expressed (CRNDE) directly interacts with miR-384. A, Bioinformatics analysis revealed the predicted binding sites between CRNDE and miR-384. B, Luciferase reporter assay demonstrated miR-384 mimics significantly decreased the luciferase activity of CRNDE-wt in HEK293T cells, while miR-384 mimics did not affect the luciferase activity of CRNDE-mut. C, CRNDE knockdown in PANC-1 and SW1990 cells markedly increased the miR-384 expression compared to negative control. D, There was no obvious change in CRNDE expression after transfection with miR-384 mimics in PANC-1 and SW1990 cells. E and F, MiR-384 expression was significantly downregulated in pancreatic cancer tissues and cell lines compared with adjacent normal tissues and normal pancreatic cells. G, Correlation analysis revealed the negative relationship between CRNDE and miR-384 expression in pancreatic cancer tissues. **P < .01, ***P < .001 implicated in the impacts of CRNDE knockdown on pancreatic cancer cell growth as well as metastasis. MiR-384 inhibitor or negative con- 
| IRS1 is a direct target of miR-384 in pancreatic cancer
With the help of bioinformatics analyses (TargetScan), we discovered that IRS1 was a potential target of miR-384 ( Figure 5A ). To assure that there was a direct interaction between miR-384 and IRS1, a wild type or mutant IRS1 3′ UTR luciferase reporter vector was con- Figure 5F ). These evidences demonstrated that IRS1 was a direct target of miR-384 in pancreatic cancer.
| CRNDE positively regulates IRS1 through modulating miR-384
Subsequently, we explored whether CRNDE regulated IRS1 expression in pancreatic cancer cells. It was revealed by the qRT-PCR and
Western blot analysis that knockdown of CRNDE resulted into a marked decrease in the mRNA and protein levels of IRS1 in PANC-1 and SW1990 cells, while downregulation of miR-384 could restore IRS1 expression ( Figure 6A,B) . Thereafter, we performed the examination of the potential correlation between the expression levels of CRNDE and IRS1 in pancreatic cancer tissues, a positive correlation between CRNDE and IRS1 expression was observed ( Figure 6C ).
Taken together, these results suggested that CRNDE could positively regulate IRS1 expression through modulating miR-384.
| CRNDE knockdown inhibits pancreatic cancer tumour growth and metastasis in vivo
We further explore the function of CRNDE in pancreatic cancer in vivo. Stable PANC-1 cells transfected with CRNDE shRNA, and negative control was injected subcutaneously into nude mice. Continuous measurements of tumour growth were taken for every 7 days, followed by the tumour excision and weighing on the 35 days after injection. Knockdown of CRNDE significantly suppressed the average tumour volume and weight, in comparison with negative control group ( Figure 7A,B) . The expression of miR-384 was markedly increased in the excised tumours from the sh-CRNDE group, in comparison with that in sh-NC group ( Figure 7C) . Moreover, the mRNA and protein expression levels of IRS1 in excised tumours appeared to be lower in the sh-CRNDE group ( Figure 7D ). Ki-67 staining was also performed to measure the cell proliferation in tumour tissues of nude mice, and the results showed that knockdown of CRNDE inhibited cell proliferation in vivo ( Figure 7E ). 
| DISCUSSION
It has been reported that lncRNA CRNDE is upregulated in several kinds of cancers. [14] [15] [16] In this research work, we initially detected the expression levels of CRNDE in 58 pairs of primary pancreatic cancer can function as a signal adaptor protein in oncogenic transformation F I G U R E 7 Colorectal neoplasia differentially expressed (CRNDE) knockdown inhibits pancreatic cancer tumour growth and metastasis in vivo. A, The tumour volume curve of nude mice was analysed. B, The tumour weights of nude mice were measured. C, The expression level of miR-384 in tumours of nude mice was detected by quantitative real-time PCR (qRT-PCR). D, qRT-PCR and Western blot analysis were performed to examine the mRNA and protein expression levels of insulin receptor substrate 1 (IRS1) in tumours of nude mice. E, Knockdown of CRNDE significantly decreased the percentage of Ki-67 positive cells in tumours of nude mice. F, The number of visible metastatic nodules on the lung surface was counted. *P < .05, **P < .01, ***P < .001
by coordinating and amplifying many signals in tumour cells. 35 Wang et al 36 showed that IRS1 expression was significantly boosted 
| CONCLUSIONS
In conclusion, we identified CRNDE as an oncogene that performed a pivotal function in cell proliferation and metastasis of pancreatic cancer. Furthermore, CRNDE could positively regulate IRS1 expression through modulation of miR-384 in pancreatic cancer cells. Our study suggested that CRNDE is likely to serve as an efficient therapeutic approach for pancreatic cancer treatment.
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